Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 5.72
+0.08 (1.42%)
Jul 30, 2026, 3:00 PM CST
SHA:605199 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,289 | 3,049 | 6,374 | 6,066 | 6,410 | 9,971 | |
Market Cap Growth | -38.76% | -52.17% | 5.08% | -5.37% | -35.71% | 3.32% |
Enterprise Value | 3,439 | 4,300 | 7,596 | 7,039 | 6,749 | 10,111 |
Last Close Price | 5.72 | 7.62 | 15.93 | 14.97 | 15.82 | 24.60 |
PE Ratio | - | - | - | 558.97 | 74.81 | 138.22 |
PS Ratio | 3.22 | 3.38 | 4.51 | 3.38 | 4.23 | 7.37 |
PB Ratio | 5.33 | 6.66 | 8.58 | 5.70 | 6.31 | 10.72 |
P/TBV Ratio | 11.79 | 13.82 | 12.60 | 7.11 | 7.03 | 12.25 |
P/FCF Ratio | 9.33 | 57.33 | - | - | - | - |
P/OCF Ratio | 7.70 | 22.28 | - | 214.70 | 26.85 | 97.29 |
EV/Sales Ratio | 4.84 | 4.77 | 5.37 | 3.92 | 4.45 | 7.47 |
EV/EBITDA Ratio | - | - | - | 94.98 | 46.94 | 86.08 |
EV/EBIT Ratio | - | - | - | 323.73 | 69.20 | 139.08 |
EV/FCF Ratio | 14.02 | 80.86 | - | - | - | - |
Debt / Equity Ratio | 2.75 | 2.66 | 1.88 | 1.21 | 0.67 | 0.54 |
Debt / EBITDA Ratio | - | - | - | 15.90 | 4.60 | 4.13 |
Debt / FCF Ratio | 4.82 | 22.87 | - | - | - | - |
Net Debt / Equity Ratio | 2.57 | 2.49 | 1.54 | 0.71 | 0.20 | 0.01 |
Net Debt / EBITDA Ratio | -5.94 | -7.94 | -6.66 | 10.24 | 1.42 | 0.10 |
Net Debt / FCF Ratio | 4.51 | 21.40 | -3.75 | -1.65 | -1.33 | -0.33 |
Asset Turnover | 0.26 | 0.32 | 0.48 | 0.68 | 0.74 | 0.83 |
Inventory Turnover | 1.64 | 1.87 | 2.05 | 3.61 | 3.02 | 2.74 |
Quick Ratio | 0.39 | 0.36 | 0.47 | 0.95 | 0.89 | 1.07 |
Current Ratio | 0.63 | 0.61 | 0.85 | 1.27 | 1.18 | 1.37 |
Return on Equity (ROE) | -56.33% | -47.37% | -29.84% | 1.63% | 8.71% | 7.53% |
Return on Assets (ROA) | -6.45% | -5.38% | -5.21% | 0.52% | 2.99% | 2.77% |
Return on Invested Capital (ROIC) | -18.35% | -13.74% | -13.28% | 0.90% | 7.87% | 6.90% |
Return on Capital Employed (ROCE) | -24.10% | -20.60% | -16.10% | 1.20% | 7.80% | 7.50% |
Earnings Yield | -14.89% | -9.43% | -4.31% | 0.18% | 1.34% | 0.72% |
FCF Yield | 10.72% | 1.74% | -4.79% | -7.60% | -2.40% | -0.35% |
Dividend Yield | - | - | - | 0.83% | - | - |
Payout Ratio | - | - | - | 290.87% | 16.75% | 102.23% |
Buyback Yield / Dilution | 0.04% | -0.34% | -9.97% | 11.35% | -1.81% | -5.55% |
Total Shareholder Return | 0.04% | -0.34% | -9.97% | 12.18% | -1.81% | -5.55% |